STOCK TITAN

Quoin Pharmaceuticals: StemPoint reports 9.9% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Quoin Pharmaceuticals Ltd. (QNRX) is the issuer whose shares are covered by ownership reports from StemPoint Capital LP, StemPoint Capital Management GP LLC and Michelle Ross; each may be deemed to beneficially own 506,983 American Depositary Shares (ADS), or 9.9% of the class.

The ownership calculation uses 4,804,161 ADS outstanding as of September 16, 2026, and includes shares acquirable under warrants subject to a 9.99% beneficial ownership limitation. It excludes 107,762 ADS underlying pre-funded warrants.

Beneficial ownership 506,983 ADS Each reporting person may be deemed to beneficially own this amount.
Percent of class 9.9% Reported beneficial ownership for each reporting person.
ADS outstanding 4,804,161 ADS As of September 16, 2026; used in the ownership calculation.
Beneficial ownership limitation 9.99% Limitation applicable to the warrants.
ADS excluded from calculation 107,762 ADS ADS underlying pre-funded warrants excluded from the ownership calculation.
Ordinary shares per ADS 35 ordinary shares per ADS Each ADS represents thirty-five ordinary shares.
American Depositary Shares technical
"American Depositary Shares, each representing thirty-five (35) Ordinary Shares"
American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.
Pre-Funded Warrants financial
"shares of ADS through the exercise of a pre-funded warrant"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
Beneficial Ownership Limitation regulatory
"subject to the Beneficial Ownership Limitation"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
Rule 13d-3(d)(1)(i) regulatory
"in accordance with Rule 13d-3(d)(1)(i) under the Act"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many QNRX ADS do the reporting persons beneficially own?

StemPoint Capital LP, StemPoint Capital Management GP LLC and Michelle Ross may each be deemed to beneficially own 506,983 ADS, reported as 9.9% of the class.

What ownership limit applies to QNRX warrants?

The warrants are subject to a 9.99% beneficial ownership limitation. The ownership calculation excludes 107,762 ADS underlying pre-funded warrants and uses 4,804,161 ADS outstanding as of September 16, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





74907L409

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G




Comment for Type of Reporting Person: StemPoint Capital Management GP LLC is a limited liability company.


SCHEDULE 13G





SCHEDULE 13G



StemPoint Capital LP
Signature:/s/ Sean C. Tan
Name/Title:Sean C. Tan, Authorized Signatory
Date:11/16/2026
StemPoint Capital Management GP LLC
Signature:/s/ Sean C. Tan
Name/Title:Sean C. Tan, Authorized Signatory
Date:11/16/2026
Michelle Ross
Signature:/s/ Michelle Ross
Name/Title:Michelle Ross
Date:11/16/2026
Exhibit Information

JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)

Keep reading